Rznomics Inc.

Public

Rznomics Inc. is now publicly traded

The data on this page reflects Rznomics Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

VC Round

Dec 23, 2023

Est. Valuation at Exit

$100.07M

Total Funding Raised

$55.59M

Company Overview

Rznomics Inc. is a clinical-stage biopharmaceutical company that develops RNA-based gene therapies for cancers and intractable diseases using its proprietary trans-splicing ribozyme platform.

AI Layer

Non-AI

Keywords

RNA therapeuticsribozymeRNA editinggene therapyanticancer therapybiotechnologyhepatocellular carcinomaHCCdrug discoverybiotechclinical trialstherapeutic platformoncologytechnology licensinggenetic medicine

Rznomics Inc. Comparables

Compare Rznomics Inc. with similar companies based on industry and business-model similarity.

Rznomics Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
エディットフォース株式会社	76%
Ethonova	63%
Sotirion Biosciences	51%

View all Comparables

Rznomics Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Dec 23, 2023
Series C	Jun 7, 2022
Series A	Sep 20, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Seong-Wook Lee

CEO & Founder

Founding Team

Rznomics Inc. Investors

Notable investors and investment history

Rznomics Inc. investors
Investor	Rounds
Shinhan Venture Investment	Series C
UTC Investment	Series C
KB Investment	VC Round
Synergy IB Investment	Series A
QUAD Investment Management	Series A
IBK Capital	Series C
LSK Investment	Series A

View all Investors

Rznomics Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Rznomics Inc. Filings

SEC and related filings with document metadata.

Firmographic Details

Headquarters—

Employee Range15

Year Founded2017

Last FundingDec 23, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?